paxlovid

AMA Update 432: Paxlovid and measles outbreak news, plus MMR shot & RSV vaccine for babies

When did COVID start in the US? Should I take Paxlovid? What is the COVID death toll? Where is the measles outbreak? Is measles eliminated in the US? What is the RSV vaccine recommendations for children?

Our guest is AMA’s Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH. American Medical Association CXO Todd Unger hosts.

📋 CDC guidelines for RSV in infants and young children: https://www.cdc.gov/rsv/high-risk/infants-young-children.html

💊 Find COVID-19 medications near you: https://treatments.hhs.gov/

🧰 ASPR COVID Treatment Locator Tool for doctors and health care providers: https://aspr.hhs.gov/COVID-19/Therapeutics/updates/Pages/important-update-11March2024.aspx

📧 Administration for Strategic Preparedness and Response email contact: COVID19.Therapeutics@hhs.gov

🔍 CDC website for the New Vaccine Surveillance Network: https://www.cdc.gov/surveillance/nvsn/index.html

🧪 Do COVID tests expire? Check #FDA COVID test expiration date extensions here: https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/home-otc-covid-19-diagnostic-tests#list

💉 Searching for «COVID vaccine near me»? Find vaccines in your area at: https://www.vaccines.gov/find-vaccines/

🩺 The AMA is your powerful ally in patient care. Join now: https://bit.ly/AMAJoinRenew

Read More

AMA Update 414: How to prevent measles, who should take Paxlovid, plus the latest research on COVID and pregnancy

How is measles spread? In this episode: MMR vaccine age, signs of measles, new studies on maternal COVID vaccination, who should get Paxlovid, and chronic COVID-19.

AMA’s Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH, shares what doctors need to know about why measles cases are on the rise both here and abroad. Also a look at COVID vaccination during pregnancy and its positive impact on newborns, as well as new research data on the long-term effects of COVID known as «chronic COVID». American Medical Association CXO Todd Unger hosts.

🦠 CDC measles cases and outbreaks: https://www.cdc.gov/measles/cases-outbreaks.html

📋CDC measles fact sheet PDF: https://www.cdc.gov/measles/downloads/Measles-fact-sheet-508.pdf

🚼 New COVID 19 pregnancy study – Respiratory distress in SARS-CoV-2 exposed uninfected neonates followed in the COVID Outcomes in Mother-Infant Pairs (COMP) Study in Nature Communications: https://www.nature.com/articles/s41467-023-44549-5

💊 NIH website for Paxlovid drug interactions: https://www.covid19treatmentguidelines.nih.gov/therapies/antivirals-including-antibody-products/ritonavir-boosted-nirmatrelvir–paxlovid-/paxlovid-drug-drug-interactions/

🔬 New study in Science Translational Medicine on SARS-CoV-2 viral clearance and evolution varies by type and severity of immunodeficiency: https://www.science.org/doi/10.1126/scitranslmed.adk1599

🩺 The AMA is your powerful ally in patient care. Join now: https://bit.ly/AMAJoinRenew

Read More

AMA Update 405: New COVID variant JN.1 symptoms, latest studies on Paxlovid rebound and Hydroxychloroquine

An in-depth look at the latest wave of respiratory infections sweeping the country. AMA’s Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH, discusses trends in COVID, flu and RSV infections, details of the latest COVID variant, and the return of mask mandates. Plus, the low use of Paxlovid and deaths linked to the use of hydroxychloroquine to treat COVID during the first wave of the pandemic. American Medical Association CXO Todd Unger hosts.

💧 Wastewater COVID dashboard via CDC National Wastewater Surveillance System (NWSS): https://www.cdc.gov/nwss/index.html

💉 Searching for «flu vaccine near me» or «cdc.gov vaccines»? Find vaccines in your area at: https://www.vaccines.gov/find-vaccines/

🗺️ CDC FluView Weekly US Map and Influenza Summary Update: https://www.cdc.gov/flu/weekly/usmap.htm

🦠 Free at home COVID tests by mail still available: https://www.covid.gov/tests

🧪 Check expired COVID test expiration date extensions here: https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/home-otc-covid-19-diagnostic-tests#list

💊 Learn more about the Home Test to Treat program: https://www.test2treat.org/

🔬 National Institutes of Health’s «Paxlovid (nirmatrelvir/ritonavir) effectiveness against hospitalization and death in N3C: A target trial emulation study»: https://pubmed.ncbi.nlm.nih.gov/37398261/

📈 Hydroxychloroquine study «Deaths induced by compassionate use of hydroxychloroquine during the first COVID-19 wave: an estimate» in Biomedicine & Pharmacotherapy journal: https://www.sciencedirect.com/science/article/pii/S075333222301853X

📊 Nature Communications study «Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials»: https://www.nature.com/articles/s41467-021-22446-z

🩺 The AMA is your powerful ally in patient care. Join now: https://bit.ly/AMAJoinRenew

Read More

AMA Update 301: Long COVID: New research, common symptoms, long-term effects and treatments with Akiko Iwasaki, PhD

Akiko Iwasaki, PhD, returns to AMA Update to share the latest science behind long COVID, including how many people are still suffering, most common symptoms and what we know about treatments like Paxlovid. She also shares guidance for physicians on diagnosing long COVID, treating post-COVID patients and new research to watch. American Medical Association CXO Todd Unger hosts.

Read More

AMA Update 275: Candida auris, Paxlovid and maternal mortality rates with Andrea Garcia, JD, MPH

AMA Vice President of Science, Medicine and Public Health Andrea Garcia, JD, MPH, covers the latest news physicians need to know, including: new updates from the FDA on Paxlovid, data from a recently released study on maternal mortality rates increasing in the U.S., and the CDC’s warning on the spread of a deadly fungus, Candida auris. American Medical Association CXO Todd Unger hosts.

Read More

AMA Update 231: COVID cases are on the rise ahead of winter holidays with Andrea Garcia, JD, MPH

AMA Vice President of Science, Medicine and Public Health Andrea Garcia, JD, MPH, covers the latest on coronavirus spread and infection trends headed into the holidays. Also discussing RSV, the spike in flu cases and influenza antiviral treatments. American Medical Association CXO Todd Unger hosts.

Read More

AMA Update 184: New Paxlovid study data, monkeypox cases, U.S. life expectancy and more with Andrea Garcia, JD, MPH

Free COVID tests, vaccines and treatments could be ending soon. AMA’s Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH, also covers the continued decline in U.S. life expectancy and FDA’s authorization of Moderna and Pfizer boosters for fall. American Medical Association CXO Todd Unger hosts.

Read More

AMA Update 168: Peter Hotez, MD, PhD, on not waiting for fall to get boosted

2022 Nobel Peace Prize nominee Peter Hotez, MD, PhD, discusses his coronavirus vaccine, CorbeVax, as well as his Paxlovid rebound infection experience, and growing concerns around monkeypox. American Medical Association CXO Todd Unger hosts.

Dr. Peter Hotez is dean of the National School of Tropical Medicine at Baylor College of Medicine, and co-director of the Texas Children’s Hospital Center for Vaccine Development in Houston.

Read More

AMA Update 153: COVID infections are increasing across the U.S. with Andrea Garcia, JD, MPH

AMA CXO Todd Unger reviews COVID-19 case trends coming out of the long weekend with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering Paxlovid treatments and «rebound infections,» monkeypox infections, and the AMA’s statement on the Texas elementary shootings that have devastated our nation.

Read More

AMA Update 151: Paxlovid side effects, treatment timelines and more with John Farley, MD, MPH

AMA CXO Todd Unger discusses what physicians and patients need to know about Paxlovid with John Farley, MD, MPH, director of the Office of Infectious Diseases in the Center for Drug Evaluation and Research’s Office of New Drugs at the FDA.

For more information on Paxlovid from the FDA, visit: https://www.fda.gov/drugs/news-events-human-drugs/fda-updates-paxlovid-health-care-providers

Read More